PayPal accepted MORE INFO

Close Notification

Your cart does not contain any items

$536.00

Hardback

We can order this in for you
How long will it take?

QTY:

CRC Press Inc
23 April 1993
Infectious & contagious diseases; Chemotherapy; Renal medicine & nephrology; Urology & urogenital medicine
This reference brings together all aspects of renal cell carcinoma, and provides a basis for understanding the disease's origin, progression and responses to immunotherapy. Examining the current status of cytokine, cell-based and chemotherapeutic methods of treatment, this book: discusses the clinical presentation of advanced renal carcinoma and its therapeutic challenges; reviews prognostic factors and the management of renal cell carcinoma occurring with von Hippel-Landau syndrome; summarizes efforts to identify the tumour suppressor gene deleted from chromosome 3 in most renal cell carcinomas; explicates the role of oncogenes in the progression of renal cell cancer and the molecular correlates of responses to interferon-alpha treatment; details the latest laboratory efforts to establish gene therapy for tumour treatment by transfection of cytokine genes in murine model systems; focuses on biologic response modifier therapy in humans, including cell-mediated immune responses and adoptive immunotherapy; presents preclinical and clinical studies of interleukin-2 alone, in combination with othe cytokines, and with chemothrapeutic agents; and addresses studies on the tumour necrosis factor and low- and high-dose interferon-alpha.
By:   Eric A. Klein
Edited by:   Ronald M. Bukowski, James H. Finke
Imprint:   CRC Press Inc
Country of Publication:   United States
Dimensions:   Height: 279mm,  Width: 216mm,  Spine: 23mm
Weight:   726g
ISBN:   9780824790332
ISBN 10:   0824790332
Pages:   368
Publication Date:   23 April 1993
Audience:   College/higher education ,  Professional and scholarly ,  Professional & Vocational ,  A / AS level ,  Further / Higher Education
Format:   Hardback
Publisher's Status:   Active

See Also